ESC 365 - Unveiling the benefits of Lp(a) testing

Open Access

Unveiling the benefits of Lp(a) testing

Session: Lp(a): not so "little" anymore the role of Lp(a) in cardiovascular risk assessment and clinical practice

Topic: Lipids

Speaker: Doctor C. Ballantyne (Houston, US)

Sponsored by Novartis Pharma AG

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)

29 presentations

3 followers

6 more presentations in this session

Welcome and introductions

Speaker: Doctor J. Cegla (London, GB)

Patient testimonial video

Lp(a) testing is simple

Speaker: Professor F. Kronenberg (Innsbruck, AT)

Lp(a) is actionable now

Speaker: Professor I. Gouni-Berthold (Cologne, DE)

Q&A

Access the full session

Lp(a): not so "little" anymore the role of Lp(a) in cardiovascular risk assessment and clinical practice

Speakers: Doctor C. Ballantyne, Doctor J. Cegla, Professor F. Kronenberg, Professor I. Gouni-Berthold

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources